Compound class:
Synthetic organic
Comment: Compound 10 is a modulator of adenosine receptor (AR) activity. It acts as a dual adenosine A1R inverse agonist/A2A/2BR antagonist [1]. The compound exhibits favourable half-life values in rat and human plasma (≥240 min in both species) and is orally bioavailable.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Compound 10 has been shown to reduce experimentally-induced neuropathic pain in mice [1]. The antineuropathic effect of compound 10 was completely blocked by a selective antagonist of the α7 subtype nicotinic acetylcholine receptor, which implicates positive modulation of this ion channel in the pharmacodynamic mechanism of compound 10. |
Selectivity at GPCRs | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|